Current funding and collaborations:
British Skin Foundation PhD studentship (2024-2027): Stress hormone metabolism - a novel anti-fibrotic therapeutic pathway for chronic wounds. Dr Catherine Wright (GCU) In collaboration with Dr Steven Patterson and Dr Kate McAuley (GCU); Dr Begonya Alcacer-Pitarch, Dr Ana Tiganescu and Dr Christopher Wasson (University of Leeds).
Previous funding and collaborations:
British Skin Foundation PhD studentship (2020 – 2023): The control of the gap junction protein Connexin 43 in normal keratinocytes and healing wounds. awarded Prof Sheila Graham (University of Glasgow https://www.gla.ac.uk/researchinstitutes/iii/staff/sheilagraham/) and Dr Patricia Martin. PhD student Harry Scott worked jointly between UoG and GCU on this project. https://www.britishskinfoundation.org.uk/bsf-research-funding #Connexins
SULSA Optical Imaging Proof of Principle funding (2019-2021): Skin Deep: New mesoscopic imaging of large tissue volumes at high resolution awarded to Dr Patricia Martin and Professor Gail McConnell (University of Strathclyde https://www.strath.ac.uk/staff/mcconnellgailprof/ ). Industrial partner Tissue Solutions https://www.tissue-solutions.com/. We accessed human skin from the tissue bank with a view to image at high resolution large tissue volumes of normal and diseased skin. GCU matched funded this grant to support the tissue bank and our Research Assistant Dr Boatemaa Ofori-Frimpong.
SULSA ECR development award 2020 (funding period: February-June 2021): The GCU Tissue Bank and Mesoscopic deep imaging of human tissue. Awarded to Dr Boatemaa Ofori-Frimpong.
Animal Free Research (2014-2017): Improving access to human material for diabetes research. Awarded to Dr Catherine Wright and Prof Ann Graham (GCU)
https://www.animalfreeresearchuk.org/project/improving-access-to-human-material-for-diabetes-research/
Psoriasis Association PhD studentship (2015-2018): A role for connexin-mediated signalling events in the pathogenesis of psoriasis. Awarded to Dr Patricia Martin and Dr Mozheh Zamiri (consultant dermatologist). PhD student Erin O’Shaughnessy
https://www.psoriasis-association.org.uk/research/researchresults
International collaborations:
We have supplied tissue to Prof A Baker, University of Texas Austin with several significant publication outputs related https://www.bme.utexas.edu/people/faculty-directory/baker.
Our industrial partners are currently AstraZenca and TCypher Bio.
We hold skin tissue blocks from >50 individuals (diabetic and non-diabetic). We have access to matched proximal and distal leg biopsies from diabetic and normal patients undergoing vascular surgery. On application we work with our Dermatology colleagues and can provide skin biopsies for conditions such as psoriasis and atopic dermatitis.
Our ethics covers the following applications:
- Fixed, wax embedded skin tissue
- Primary dermal fibroblasts
- Primary epidermal keratinocytes
- Frozen skin tissue for DNA, RNA or protein extraction
- Generation of iPS cells from patient related material
- Matched bloods from patients
Please get in touch to request an application form for access to samples. Applications will be assessed by the GCU Skin Research Tissue Bank Committee and approved on the basis of their scientific merit.
Contact details for formal or informal enquiries: skintissuebank@gcu.ac.uk
In addition to cost recovery, applicants are expected to cover transport costs and supply appropriate customs declarations where necessary. Successful applicants are also expected to provide annual research updates and include an acknowledgement in all publications using material supplied by the tissue bank. Further details are available on request.
Peer reviewed journal articles
Scott H, Dong L, Stevenson A, MacDonald AI, Srinivasan S, Massimi P, Banks L, Martin PE, Johnstone SR, Graham SV: The human discs large protein 1 interacts with and maintains connexin 43 at the plasma membrane in keratinocytes. Journal of cell science 2023, 136(11).
Bastaki KM, Tarlton JMR, Lightbody RJ, Graham A, Martin PE: Homo Sapiens (Hsa) -microRNA (miR)-6727-5p Contributes to the Impact of High –Density Lipoproteins on Fibroblast Wound Healing In Vitro. Membranes 2022,12(2):154.
Takematsu E, Massidda M, Auster J, Chen PC, Im B, Srinath S, Canga, S, Singh A, Majid, M, Sherman, M, Dunn, A, Graham A, Martin P, Baker, AB. Transmembrane stem cell factor protein therapeutics enhance revascularization in ischemia without mast cell activation. Nature Communications. 2022 May 6;13:2497. doi: 10.1038/s41467-022-30103-2
O’Shaughnessy EM, Duffy W, Garcia-Vega L, Hussey K, Burden AD, Zamiri M, Martin, PE. Dysregulation of Connexin Expression Plays a Pivotal Role in Psoriasis. International Journal of Molecular Sciences. 2021;22(11):6060. Doi doi:10.3390/ijms22116060
Takematsu E, Spencer A, Auster J, Chen PC, Graham A, Martin P, Baker AB: Genome wide analysis of gene expression changes in skin from patients with type 2 diabetes. PLoS One 2020, 15(2):e0225267.
Martin PE, O'Shaughnessy EM, Wright CS, Graham A: The potential of human induced pluripotent stem cells for modelling diabetic wound healing in vitro. Clin Sci (Lond) 2018, 132(15):1629-1643.
Faniku C, O'Shaughnessy E, Lorraine C, Johnstone SR, Graham A, Greenhough S, Martin PEM: The Connexin Mimetic Peptide Gap27 and Cx43-Knockdown Reveal Differential Roles for Connexin43 in Wound Closure Events in Skin Model Systems. International journal of molecular sciences 2018, 19(2).
Monteforte AJ, Lam B, Das S, Mukhopadhyay S, Wright CS, Martin PE, Dunn AK, Baker AB: Glypican-1 nanoliposomes for potentiating growth factor activity in therapeutic angiogenesis. Biomaterials 2016, 94:45-56.
Das S, Singh G, Majid M, Sherman MB, Mukhopadhyay S, Wright CS, Martin PE, Dunn AK, Baker AB (2016) Syndesome Therapeutics for Enhancing Diabetic Wound Healing. Adv Healthc Mater. 5(17):2248-60. doi: 10.1002/adhm.201600285
Lorraine C, Wright CS, Martin PE: Connexin43 plays diverse roles in co-ordinating cell migration and wound closure events. Biochem Soc Trans 2015, 43(3):482-488.
Martin PE: Connexins help fill the Gap: markers and therapeutic targets for chronic nonhealing wounds. Br J Dermatol 2015, 173(5):1123-1124.
Wright CS, Berends RF, Flint DJ, Martin PE: Cell motility in models of wounded human skin is improved by Gap27 despite raised glucose, insulin and IGFBP-5. Exp Cell Res 2013, 319(4):390-401.
Wright CS, Pollok S, Flint DJ, Brandner JM, Martin PE: The connexin mimetic peptide Gap27 increases human dermal fibroblast migration in hyperglycemic and hyperinsulinemic conditions in vitro. J Cell Physiol 2012, 227(1):77-87.
Pollok S, Pfeiffer AC, Lobmann R, Wright CS, Moll I, Martin PE, Brandner JM: Connexin 43 mimetic peptide Gap27 reveals potential differences in the role of Cx43 in wound repair between diabetic and non-diabetic cells. J Cell Mol Med 2011, 15(4):861-873.